Solventum Corporation, a cutting-edge healthcare company, shows a robust performance across its core segments. With its diversification in Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration, SOLV is well-positioned to meet diverse market demands. The stock demonstrates potential for stability given its strong fundamentals.
The fundamental metrics for Solventum Corporation are strong, with the company achieving a rating of A-. Each metric showcases the company's sound financial health.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return On Equity | 5 | |
| Return On Assets | 5 | |
| Debt To Equity | 1 | |
| Price To Earnings | 3 | |
| Price To Book | 2 |
Historical scores indicate consistent performance with slight deviations in the overall rating, reflecting market conditions and operational adjustments.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-03-12 | 4 | 5 | 5 | 5 | 1 | 3 | 2 |
| Previous | 0 | 5 | 5 | 5 | 1 | 3 | 2 |
Analysts provide optimistic forecasts with a high target of $105, a low of $77, giving a median of $100, and a consensus of $95.8.
| High | Low | Median | Consensus |
|---|---|---|---|
| $105 | $77 | $100 | $95.8 |
The stock sentiment reflects a positive outlook with several buy recommendations and limited sell options, indicating confidence in future performance.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 7 | |
| Hold | 3 | |
| Sell | 1 | |
| Strong Sell | 0 |
Solventum Corporation shows a promising path forward, driven by robust fundamentals and diverse market engagements. The stock is supported by a strong analyst consensus and price targets suggest a potential for growth. Although a high debt-to-equity ratio might pose a risk, the company's overall stability and market innovation mitigate potential downsides. Investors should be cautious of market volatility but can see consistent long-term value.